Silvergate Pharmaceuticals, Inc.;University of Kansas
发明人:
Lian G. Rajewski,Roger A. Rajewski,John L. Haslam,Kathleen Heppert,Michael C. Beckloff,Frank Segrave,Robert Mauro,Peter Colabuono
申请号：
US14433502
公开号：
US20150258027A1
申请日:
2013.10.02
申请国别(地区):
US
年份:
2015
代理人:
摘要：
Provided herein are stable enalapril powder compositions for oral liquid formulation. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and asymptomatic left ventricular dysfunction.
